Cao et al.29 reported only a modest correlation between sarcosine levels and PCa progression, and the prognostic value of sarcosine was found to be inferior to the more robust prostate cancer gene 3 (PCA3) and PSA biomarker30. This evidence concerns the gene PCA3 and posterior cortical atrophy.